Fri, February 19, 2021
Thu, February 18, 2021
Wed, February 17, 2021
Tue, February 16, 2021
Mon, February 15, 2021
Fri, February 12, 2021
Thu, February 11, 2021
Wed, February 10, 2021
Tue, February 9, 2021

Brian Abrahams Maintained (VRTX) at Buy and Held Target at $264 on, Feb 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-264-on-feb-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $264 on, Feb 15th, 2021.

Brian has made no other calls on VRTX in the last 4 months.



There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $250 on, Tuesday, February 2nd, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $251 on, Tuesday, January 19th, 2021


These are the ratings of the 8 analyists that currently disagree with Brian


  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $284 on, Tuesday, February 2nd, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $347 on, Tuesday, February 2nd, 2021
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $280 on, Tuesday, February 2nd, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $288 on, Friday, November 20th, 2020
  • Vincent Chen of "Bernstein" Initiated at Buy and Held Target at $275 on, Friday, November 20th, 2020
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $277 on, Friday, October 30th, 2020
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $307 on, Friday, October 30th, 2020
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $305 on, Thursday, October 15th, 2020

Publication Contributing Sources